Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susmita Mondal

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Advanced Healthcare Materials|December 16, 2020
Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical ModelAniruddha Adhikari, Susmita Mondal, Monojit Das, et al.
Chemmedchem|November 15, 2024
A Pleiotropic Nanomedicine Mitigates Splenic Hyperplasia, Ineffective Erythropoiesis, G6PDH Anomaly through Redox Buffering in Preclinical Mice ModelMonojit Das, Susmita Mondal, Ria Ghosh, et al.
Pediatric Research|July 6, 2022
Chemoprevention of bilirubin encephalopathy with a nanoceutical agentAniruddha Adhikari, Vinod K Bhutani, Susmita Mondal, et al.
Scientific Reports|November 7, 2022
Molecular co-localization of multiple drugs in a nanoscopic delivery vehicle for potential synergistic remediation of multi-drug resistant bacteriaAmrita Banerjee, Dipanjan Mukherjee, Arpan Bera, et al.
Physical Chemistry Chemical Physics : PCCP|April 29, 2026
Local-friction governs water mobility in hydrogels acting as extracellular mimicsMonojit Das, Jayanta Mondal, Naglaa Atif Alhadi Rahma, et al.
Communications Biology|August 27, 2021
Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in miceAniruddha Adhikari, Susmita Mondal, Tanima Chatterjee, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesBoris Winterhoff, Luisa Freyer, Edward Hammond, et al.
International Journal of Cancer|September 19, 2018
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancersSusmita Mondal, Debarshi Roy, Sayantani Sarkar Bhattacharya, et al.
Iscience|September 16, 2022
A nano erythropoiesis stimulating agent for the treatment of anemia and associated disordersMonojit Das, Susmita Mondal, Ria Ghosh, et al.
Oncotarget|September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancerSusmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Advanced Healthcare Materials|December 16, 2020
Incorporation of a Biocompatible Nanozyme in Cellular Antioxidant Enzyme Cascade Reverses Huntington's Like Disorder in Preclinical ModelAniruddha Adhikari, Susmita Mondal, Monojit Das, et al.
Chemmedchem|November 15, 2024
A Pleiotropic Nanomedicine Mitigates Splenic Hyperplasia, Ineffective Erythropoiesis, G6PDH Anomaly through Redox Buffering in Preclinical Mice ModelMonojit Das, Susmita Mondal, Ria Ghosh, et al.
Pediatric Research|July 6, 2022
Chemoprevention of bilirubin encephalopathy with a nanoceutical agentAniruddha Adhikari, Vinod K Bhutani, Susmita Mondal, et al.
Scientific Reports|November 7, 2022
Molecular co-localization of multiple drugs in a nanoscopic delivery vehicle for potential synergistic remediation of multi-drug resistant bacteriaAmrita Banerjee, Dipanjan Mukherjee, Arpan Bera, et al.
Physical Chemistry Chemical Physics : PCCP|April 29, 2026
Local-friction governs water mobility in hydrogels acting as extracellular mimicsMonojit Das, Jayanta Mondal, Naglaa Atif Alhadi Rahma, et al.
Communications Biology|August 27, 2021
Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in miceAniruddha Adhikari, Susmita Mondal, Tanima Chatterjee, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesBoris Winterhoff, Luisa Freyer, Edward Hammond, et al.
International Journal of Cancer|September 19, 2018
Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancersSusmita Mondal, Debarshi Roy, Sayantani Sarkar Bhattacharya, et al.
Iscience|September 16, 2022
A nano erythropoiesis stimulating agent for the treatment of anemia and associated disordersMonojit Das, Susmita Mondal, Ria Ghosh, et al.
Oncotarget|September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancerSusmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
Pageof 9